Candidiasis in patients treated with interleukin-17 inhibitors

被引:2
作者
Baez-Gutierrez, Nerea [1 ]
Rodriguez-Ramallo, Hector [1 ]
机构
[1] Virgen Rocio Univ Hosp, Hosp Pharm Dept, Seville, Spain
关键词
D O I
10.4103/ijp.ijp_1178_20
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:244 / 245
页数:2
相关论文
共 5 条
[1]   The IL-17 pathway as a major therapeutic target in autoimmune diseases [J].
Hu, Yan ;
Shen, Fang ;
Crellin, Natasha K. ;
Ouyang, Wenjun .
YEAR IN IMMUNOLOGY, 2011, 1217 :60-76
[2]   Mucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapy [J].
Huppler, Anna R. ;
Bishu, Shrinivas ;
Gaffen, Sarah L. .
ARTHRITIS RESEARCH & THERAPY, 2012, 14 (04)
[3]   Candida infections in psoriatic patients on anti-IL17 therapy: a case series [J].
Papini, Manuela ;
Natalini, Ylenia .
JOURNAL OF DERMATOLOGICAL TREATMENT, 2018, 29 :3-4
[4]   Candida infections in patients with psoriasis and psoriatic arthritis treated with interleukin-17 inhibitors and their practical management [J].
Saunte, D. M. ;
Mrowietz, U. ;
Puig, L. ;
Zachariae, C. .
BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (01) :47-62
[5]   Anti-IL-17 monoclonal antibodies for the treatment of ankylosing spondylitis [J].
Wendling, Daniel ;
Verhoeven, Frank ;
Prati, Clement .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (01) :55-64